GMIHO Gesellschaft für medizinische Innovation

GMIHO (Gesellschaft für medizinische Innovation, Hämatologie und Onkologie) is a specialized contract research organization (CRO) based in Munich, Germany, that focuses on clinical research within the fields of hematology and oncology. The company provides comprehensive services for the planning, coordination, and execution of clinical trials, including regulatory affairs, project management, and data monitoring. GMIHO is particularly recognized for its expertise in managing both academic-led trials and industry-sponsored studies, maintaining a long-standing collaboration with the German CLL Study Group (GCLLSG). Their service portfolio covers Phase I through Phase IV clinical trials as well as non-interventional studies and registries. By facilitating high-quality clinical research, GMIHO aims to bridge the gap between medical innovation and clinical practice to improve outcomes for cancer patients.